Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

This study has been completed.

Sponsor:

Collaborator:

Napoli CTO Hospital

Information provided by:

Second University of Naples

ClinicalTrials.gov Identifier:

NCT01025934

First received: December 3, 2009

Last updated: NA

Last verified: December 2009

History: No changes posted

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

No publications provided by Second University of Naples

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. Epub 2010 Feb 5.

To Top